Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients

Blood Cancer J. 2025 Apr 8;15(1):60. doi: 10.1038/s41408-025-01274-0.
No abstract available

Publication types

  • Letter